These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 24573400)
1. Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients. Akiyama Y; Komiyama M; Miyata H; Yagoto M; Ashizawa T; Iizuka A; Oshita C; Kume A; Nogami M; Ito I; Watanabe R; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Yamaguchi K Oncol Rep; 2014 Apr; 31(4):1683-90. PubMed ID: 24573400 [TBL] [Abstract][Full Text] [Related]
2. Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma. Syed ON; Mandigo CE; Killory BD; Canoll P; Bruce JN J Clin Neurosci; 2012 Jul; 19(7):1016-21. PubMed ID: 22534618 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma. Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602 [TBL] [Abstract][Full Text] [Related]
4. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells. Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor. Schittenhelm J; Schwab EI; Sperveslage J; Tatagiba M; Meyermann R; Fend F; Goodman SL; Sipos B J Neuropathol Exp Neurol; 2013 Mar; 72(3):194-210. PubMed ID: 23399898 [TBL] [Abstract][Full Text] [Related]
7. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329 [TBL] [Abstract][Full Text] [Related]
8. Association between laminin-8 and glial tumor grade, recurrence, and patient survival. Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074 [TBL] [Abstract][Full Text] [Related]
9. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas. Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164 [TBL] [Abstract][Full Text] [Related]
10. Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis. Zou C; Shen J; Tang Q; Yang Z; Yin J; Li Z; Xie X; Huang G; Lev D; Wang J Cancer; 2012 Apr; 118(7):1845-55. PubMed ID: 22009167 [TBL] [Abstract][Full Text] [Related]
11. Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers. Prosniak M; Harshyne LA; Andrews DW; Kenyon LC; Bedelbaeva K; Apanasovich TV; Heber-Katz E; Curtis MT; Cotzia P; Hooper DC Clin Cancer Res; 2013 Jul; 19(14):3776-86. PubMed ID: 23741072 [TBL] [Abstract][Full Text] [Related]
12. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of PCDH9 predicts prognosis for patients with glioma. Wang C; Yu G; Liu J; Wang J; Zhang Y; Zhang X; Zhou Z; Huang Z J Clin Neurosci; 2012 Apr; 19(4):541-5. PubMed ID: 22300792 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma. Strojnik T; Smigoc T; Lah TT Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485 [TBL] [Abstract][Full Text] [Related]
15. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Chi DD; Merchant RE; Rand R; Conrad AJ; Garrison D; Turner R; Morton DL; Hoon DS Am J Pathol; 1997 Jun; 150(6):2143-52. PubMed ID: 9176405 [TBL] [Abstract][Full Text] [Related]
16. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma. Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494 [TBL] [Abstract][Full Text] [Related]
17. Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma. He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD Brain Tumor Pathol; 2012 Jan; 29(1):3-9. PubMed ID: 21837501 [TBL] [Abstract][Full Text] [Related]
18. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma. Alafate W; Zuo J; Deng Z; Guo X; Wu W; Zhang W; Xie W; Wang M; Wang J Pathol Res Pract; 2019 Oct; 215(10):152557. PubMed ID: 31353228 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma. He J; Deng Y; Yang G; Xie W J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496 [TBL] [Abstract][Full Text] [Related]
20. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma. Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]